GI Insights

Non-invasive assessments of liver fibrosis can be subcategorized into many different tests. What do we need to know about these increasingly popular assessments? Dr. Peter Buch is joined by Dr. Richard Sterling, professor of medicine at Virginia Commonwealth University to discuss when it is appropriate to use each of these assessments for patients with liver fibrosis.

Misconceptions around chronic idiopathic constipation can make it challenging to diagnose and treat. What do we need to know to help our patients manage this condition? Dr. Peter Buch is joined by Dr. Kyle Staller, assistant professor of medicine at the Harvard Medical School to discuss these myths and misconceptions about constipation.

Irritable bowel syndrome, or IBS, is a common disorder that can be challenging to treat. What is the best therapeutic approach to treating this condition? Dr. Peter Buch is joined by Wendy Wright, an adult and family nurse practitioner from New Hampshire, to discuss how to test and treat patients with IBS from a primary care perspective.

Recent immunotherapy approvals have changed the treatment paradigm for first and subsequent lines of treatment for patients with microsatellite-high or mismatch repair deficient metastatic colorectal cancer. Join us as we deep dive into recent and newly emergent data to better understand how to bring these advances into the clinic.

Virtual reality has shown the ability to decrease pain, reduce opioid dependence, and boost mental health. How is this digital therapeutic changing the treatment landscape for gastroenterology? Dr. Neil Nandi is joined by Dr. Brennan Spiegel, Director of the Cedars-Sinai CORE program, on his innovative research about the positive impact of virtual reality in gastroenterology.

Gastrointestinal bleeding, or GI bleeding, is a serious but common condition, and upper GI bleeding requires an individualized approach. How can we better detect and manage this condition? Dr. Peter Buch will be discussing the importance of managing upper GI bleeding with Dr. John Saltzman, Director of Endoscopy at the Brigham and Women’s Hospital.

Developed to treat psychiatric disorders, emerging evidence suggests that neuromodulators play a vital role in treating functional GI disorders. Here today is Dr. Peter Buch who will be discussing the role of neuromodulators in functional GI disorders with Dr. Douglas Drossman.

Effective communication is essential to improving the patient-provider relationship. What is the best approach a physician can take when speaking to patients with IBS? Dr. Peter Buch will discuss valuable communication strategies with Dr. Douglas Drossman, president of the Rome Foundation.

Patients with chronic diarrhea are often misdiagnosed with irritable bowel syndrome with diarrhea, or IBS-D. How can we better assess these patients to prevent misdiagnosis? Joining Dr. Peter Buch to discuss diagnostic tools and testing strategies is Dr. Lawrence Schiller, Program Director of the Gastroenterology Fellowship at Baylor University Medical Center.

Achieving the goal of enteral autonomy is one of the biggest challenges when managing patients with short bowel syndrome. Join Dr. Valeria Cohran and Dr. Kishore Iyer to learn how GLP-2 analogs can reduce the number of total parenteral nutrition (TPN) days in adults and children and even allow some patients to be successfully tapered from TPN.